Stay updated with breaking news from Amyloid levels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., March 11, 2022(Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, as well as data for ADUHELM (aducanumab-avwa) injection 100 mg/mL for intravenous use ....